PDI, Inc. Announces $48 Million in Renewal Sales Contracts

Symbols: PDII
Posted in: News, Contracts
Share

PDI, Inc. (Nasdaq: PDII) today announced the signing of a three-year agreement with a current Top 5 global pharmaceutical client and renewal of a one-year engagement with a specialty pharmaceutical client.  Approximately $48 million in revenue is expected to be generated in 2012 between both contracts.


 
 
< Previous
UPDATE: Asbury Automotive Posts Upbeat Q4 Results
Next >
Jacobs Receives Four Contracts from Arkema to Support PVC Projects in China
Share
Printer-friendly version
Send to friend
We're Loving

Benzinga's Premium Memberships

Benzinga's News Delivered Free

Brain Trust